Articles dans des revues avec comité de lecture (44)
  1. 1. Najar, M., Bouhtit, F., Rahmani, S., Bouali, A., Melki, R., Najimi, M., Lewalle, P., & Merimi, M. (2024). The immunogenic profile and immunomodulatory function of mesenchymal stromal / stem cells in the presence of Ptychotis verticillata. Heliyon, 10(3), e24822. doi:10.1016/j.heliyon.2024.e24822
  2. 2. Najar, M., Rahmani, S., Faour, W. W., Alsabri, S., Lombard, C., Fayyad Kazan, H., Sokal, E. E., Merimi, M., & Fahmi, H. (2024). Umbilical Cord Mesenchymal Stromal/Stem Cells and Their Interplay with Th-17 Cell Response Pathway. Cells, 13(2), 169. doi:10.3390/cells13020169
  3. 3. Ajith, A., Merimi, M., Arki, M. K., Hossein-khannazer, N., Najar, M., Vosough, M., Sokal, E. E., & Najimi, M. (2024). Immune regulation and therapeutic application of T regulatory cells in liver diseases. Frontiers in immunology, 15, 1371089. doi:10.3389/fimmu.2024.1371089
  4. 4. Najar, M., Fahmi, H., & Merimi, M. (2023). The Medicinal Potential of Mesenchymal Stem/Stromal Cells in Immuno- and Cancer Therapy. Biomolecules, 13(8), 1171. doi:10.3390/biom13081171
  5. 5. Najar, M., Alsabri, S., Guedi, G., Merimi, M., Lavoie, F., Grabs, D., Pelletier, J.-P., Martel-Pelletier, J., Benderdour, M., & Fahmi, H. (2023). Role of epigenetics and the transcription factor Sp1 in the expression of the D prostanoid receptor 1 in human cartilage. Frontiers in Cell and Developmental Biology, 11, 1256998. doi:10.3389/fcell.2023.1256998
  6. 6. Merimi, M., Fahmi, H., De Kock, J., Beguin, C., Burny, A., Moll, G., Poggi, A., & Najar, M. (2022). Mesenchymal Stem/Stromal Cells as a Therapeutic Tool in Cell-Based Therapy and Regenerative Medicine: An Introduction Expertise to the Topical Collection. Cells, 11(19), 3158. doi:10.3390/cells11193158
  7. 7. Bouhtit, F., Najar, M., Rahmani, S., Melki, R., Najimi, M., Sadki, K., Boukhatem, N., Twizere, J.-C., Meuleman, N., Lewalle, P., Lagneaux, L., & Merimi, M. (2022). Bioscreening and pre-clinical evaluation of the impact of bioactive molecules from Ptychotis verticillata on the multilineage potential of mesenchymal stromal cells towards immune- and inflammation-mediated diseases. Inflammation research, 71(7-8), 887-898. doi:10.1007/s00011-022-01573-3
  8. 8. Merimi, M., Rahmani, S., Afailal Tribak, A., Bouhtit, F., Fahmi, H., & Najar, M. (2022). Fundamental and Applied Advances in Stem Cell Therapeutic Research. Cells, 11(12). doi:10.3390/cells11121976
  9. 9. Najar, M., Melki, R., Khalife, F., Lagneaux, L., Bouhtit, F., Moussa Agha, D., Fahmi, H., Lewalle, P., Fayyad Kazan, M., & Merimi, M. (2022). Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization. Frontiers in Cell and Developmental Biology, 9, 716853. doi:10.3389/fcell.2021.716853
  10. 10. Najar, M., Merimi, M., Faour, W. H., Lombard, C. A., Moussa Agha, D., Ouhaddi, Y., Sokal, E. M., Lagneaux, L., & Fahmi, H. (2021). In Vitro Cellular and Molecular Interplay between Human Foreskin-Derived Mesenchymal Stromal/Stem Cells and the Th17 Cell Pathway. Pharmaceutics, 13(10). doi:10.3390/pharmaceutics13101736
  11. 11. Merimi, M., El-Majzoub, R., Lagneaux, L., Moussa Agha, D., Bouhtit, F., Meuleman, N., Fahmi, H., Lewalle, P., Fayyad Kazan, M., & Najar, M. (2021). The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings. Frontiers in Cell and Developmental Biology, 9. doi:10.3389/fcell.2021.661532
  12. 12. Berehab, M., Rouas, R., Akl, H., Duvillier, H., Journé, F., Fayyad Kazan, H., Ghanem, G. E., Bron, D., Lewalle, P., & Merimi, M. (2021). Apoptotic and non-apoptotic modalities of thymoquinone-induced lymphoma cell death: Highlight of the role of cytosolic calcium and necroptosis. Cancers (Basel), 13(14), 3579. doi:10.3390/cancers13143579
    13. << Précédent 1 2 3 4 Suivant >>